HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroleptic malignant syndrome.

Abstract
Neuroleptic malignant syndrome is an uncommon, occasionally lethal reaction to drug therapy. Patients taking neuroleptic medication are usually the victims of this complex disorder, but others, such as patients with Parkinson's disease, are also at risk. The classic presentation includes autonomic instability, rigidity, hyperthermia, confusion and other neurologic symptoms. Family physicians may be the first to see these patients and must be able to make the diagnosis quickly to avoid delay in treatment.
AuthorsH D Goldwasser, J F Hooper
JournalAmerican family physician (Am Fam Physician) Vol. 38 Issue 5 Pg. 211-6 (Nov 1988) ISSN: 0002-838X [Print] United States
PMID3189125 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Bromocriptine
  • Creatine Kinase
Topics
  • Adult
  • Aged
  • Bromocriptine (therapeutic use)
  • Creatine Kinase (blood)
  • Diagnosis, Differential
  • Family Practice
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neuroleptic Malignant Syndrome (diagnosis, drug therapy)
  • Pneumonia, Pneumococcal (diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: